Antares Pharma, Inc. (ATRS)

[rph_investor]

I thought it was pretty nuts to post "ideas" on a presentation, unless they already have the patents on them, or they've ruled out developing these. They seem like pretty good ideas to me. They may be skipping these meds because most are given in a hospital setting and auto-injectors are not economically feasible in hospitals if there is another option. Somebody probably got chewed out for putting those pages in there.

Another idea that I'll run by everyone... most people I've seen comment seem to think Vibex QS M is scopolamine. Why would they advertise it in their pipeline even though they have not been granted the rights to it yet? Makes no sense for a reputable company to count their chickens before they hatch.

Just some thoughts.